Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Alka-Seltzer Plus extension

This article was originally published in The Tan Sheet

Executive Summary

Quick-dissolve tablets debuting for 2003 cough/cold season contain pseudoephedrine HCl, chlorpheniramine maleate for nasal congestion, sneezing, sinus pressure and runny nose, Bayer says. Alka-Seltzer Plus Ready Relief Tabs do not contain acetaminophen, as previously reported (1"The Tan Sheet" June 23, 2003, p. 10)...

You may also be interested in...



NACDS In Brief

Bayer: Alka-Seltzer Plus Ready Release quick dissolve tablets slated to ship in early August, firm says at National Association of Chain Drug Stores Marketplace in San Diego June 8-10. New delivery form "melts in your mouth" with "no water needed," labeling notes. Tablets in blister-pack 12-count boxes contain acetaminophen and pseudoephedrine, will be indicated for nasal congestion, runny nose, sneezing and sinus pressure. Consumers are advised to take two tablets for symptom relief; flavors include cool mint and orange zest. Bayer will support the line extension with television and print ads, as well as FSI drops in October, November and December...

Liquid Biopsy Company Delfi Diagnostics Raised $100M For New Class of Early Cancer Detection Test

Delfi Diagnostics will use the new funds to expand its team of cancer researchers and machine-learning experts to validate its novel approach for early cancer detection through multiple prospective clinical trials. 

Biotin And ‘Healthy Hair’: Federal Pre-emption Clips False Advertising Complaint In California

US Ninth Circuit affirms a district court’s summary judgment in favor of Target and manufacturer of Up & Up brand biotin supplement it sells. Indian manufacturer targeted in putative class-action in New York prompted FDA’s 2016 creation of import alert category for Ayurvedic supplements.

Topics

UsernamePublicRestriction

Register

LL1135415

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel